BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31021394)

  • 1. Optimal timing of hepatitis B virus DNA quantification and clinical predictors for higher viral load during pregnancy.
    Cheung KW; Seto MTY; So PL; Wong D; Mak ASL; Lau WL; Wang W; Kan ASY; Lee CP; Ng EHY
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1301-1306. PubMed ID: 31021394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 3. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing.
    Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT
    Liver Int; 2018 Jul; 38(7):1212-1219. PubMed ID: 29532580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
    Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
    Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Lu Y; Zhu FC; Liu JX; Zhai XJ; Chang ZJ; Yan L; Wei KP; Zhang X; Zhuang H; Li J
    Vaccine; 2017 Dec; 35(48 Pt B):6627-6633. PubMed ID: 29079104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.
    Samadi Kochaksaraei G; Congly SE; Matwiy T; Castillo E; Martin SR; Charlton CL; Coffin CS
    Liver Int; 2016 Nov; 36(11):1604-1610. PubMed ID: 27059287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
    Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
    World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
    Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis.
    Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H
    Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
    N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
    Xu J; Tao LL; Ma LX
    J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants.
    Singh AE; Plitt SS; Osiowy C; Surynicz K; Kouadjo E; Preiksaitis J; Lee B
    J Viral Hepat; 2011 Jul; 18(7):468-73. PubMed ID: 20546502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
    Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
    Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.